PROVIDER PROFILE · NPI 1407819444

Philip KnappMD

EndocrinologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

276

Unique beneficiaries

—

Total services

360

Distinct HCPCS

Medicare payment

$24K

Peer benchmark

Total Medicare services vs. 341 Endocrinology providers in MA — below median (cohort median 496).

PRESCRIBING · PART D · 2024

Total Rx claims

1,666

Beneficiaries

—

Total drug cost

$799K

Distinct drugs

Brand share

57.3%

Top prescribed drugs

Dulaglutide211 claims

Levothyroxine Sodium197 claims

Empagliflozin128 claims

Insulin Glargine,hum.Rec.Anlog106 claims

Alendronate Sodium88 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Philip Knapp's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
BOSTON MEDICAL CENTER CORPORATION	156	1,097
QUEST DIAGNOSTICS MASSACHUSETTS LLC	70	563
THE GENERAL HOSPITAL CORPORATION	12	50
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	11	30

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
BOSTON MEDICAL CENTER CORPORATION	128	740
BOSTON MEDICAL CENTER CORPORATION	107	750
QUEST DIAGNOSTICS MASSACHUSETTS LLC	26	165
THE GENERAL HOSPITAL CORPORATION	19	71
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	12	36

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history